Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial

Microbiology Spectrum(2024)10.1128/spectrum.01789-24Source: DataRank Database

Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial is a research paper published in Microbiology Spectrum (2024). On theSindex it has a DataRank of 0.345. It has been cited 9 times.

N/A

0.345DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.37)OA: goldTopics (52)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (7)

Abhigya Giri,Lauren Komarow,Maria Souli ORCID,Sarah B. Doernberg ORCID,Robin Patel ORCID

Live enrichment

PubMed:39679788 PMC:PMC11792449 OpenAlex:https://openalex.org/W4405447102

HHS | NIH | NIH Office of the Director

Grant: UM1AI104681

National Institutes of Health

Grant: 5UM1AI104681-03

Antibacterial Resistance Leadership Group (ARLG)

FWCI

2.37

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.01789-24

publisherhttps://doi.org/10.1128/spectrum.01789-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.01789-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39679788

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11792449

Fields of Study

Bacterial Identification and Susceptibility TestingAntibiotic Resistance in BacteriaAntibiotic Use and Resistance0301 basic medicine03 medical and health sciences0302 clinical medicineHumansBacteremiaMicrobial Sensitivity TestsAnti-Bacterial AgentsGram-Negative BacteriaGram-Negative Bacterial InfectionsDrug Resistance, BacterialBlood CultureFemaleMale

MeSH Terms

Blood CultureAnti-Bacterial AgentsFemaleGram-Negative BacteriaHumansMaleMicrobial Sensitivity TestsMiddle AgedBacteremiaGram-Negative Bacterial InfectionsDrug Resistance, Bacterial

Keywords

BacteremiaAntibioticsSepsisAntibiotic resistanceBlood cultureMedicineMicrobiologyRandomized controlled trialKlebsiellaInternal medicineIntensive care medicineBiologyEscherichia coliBloodstream InfectionsSusceptibility TestingMaleObservationMicrobial Sensitivity TestsQR1-502Anti-Bacterial AgentsGram-Negative BacteriaDrug Resistance, BacterialHumansFemaleGram-Negative Bacterial Infections